Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, IGM Biosciences Inc (NASDAQ: IGMS) closed at $7.96 up 3.38% from its previous closing price of $7.70. In other words, the price has increased by $3.38 from its previous closing price. On the day, 0.69 million shares were traded. IGMS stock price reached its highest trading level at $8.6 during the session, while it also had its lowest trading level at $7.75.
Ratios:
For a deeper understanding of IGM Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.18 and its Current Ratio is at 8.18. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on February 09, 2024, Upgraded its rating to Outperform and sets its target price to $21 from $9 previously.
On December 15, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $8.
H.C. Wainwright Downgraded its Buy to Neutral on December 07, 2023, whereas the target price for the stock was revised from $11 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 28 ’24 when BAKER BROS. ADVISORS LP bought 97,473 shares for $9.62 per share. The transaction valued at 937,632 led to the insider holds 3,753,480 shares of the business.
BAKER BROS. ADVISORS LP bought 27,844 shares of IGMS for $257,170 on Mar 27 ’24. The Director now owns 3,664,073 shares after completing the transaction at $9.24 per share. On Mar 26 ’24, another insider, BAKER BROS. ADVISORS LP, who serves as the Director of the company, bought 270,000 shares for $8.26 each. As a result, the insider paid 2,230,767 and bolstered with 3,638,533 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGMS now has a Market Capitalization of 452656544 and an Enterprise Value of 170770240. For the stock, the TTM Price-to-Sale (P/S) ratio is 220.30 while its Price-to-Book (P/B) ratio in mrq is 2.30. Its current Enterprise Value per Revenue stands at 80.174 whereas that against EBITDA is -0.674.
Stock Price History:
Over the past 52 weeks, IGMS has reached a high of $17.70, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is -27.16%, while the 200-Day Moving Average is calculated to be -7.10%.
Shares Statistics:
For the past three months, IGMS has traded an average of 263.17K shares per day and 314400 over the past ten days. A total of 33.18M shares are outstanding, with a floating share count of 20.97M. Insiders hold about 64.42% of the company’s shares, while institutions hold 38.33% stake in the company. Shares short for IGMS as of 1711584000 were 5222036 with a Short Ratio of 19.84, compared to 1709164800 on 4506673. Therefore, it implies a Short% of Shares Outstanding of 5222036 and a Short% of Float of 33.52.
